PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'BioNTech, Mainz, Germany. ugur.sahin@biontech.de.\', \'TRON gGmbH-Translational Oncology at the University Medical Center of the Johannes Gutenberg, Mainz, Germany. ugur.sahin@biontech.de.\', \'BioNTech, Mainz, Germany.\', \'Regeneron Pharmaceuticals, Tarrytown, NY, USA.\', \'Bexon Clinical Consulting, Upper Montclair, NJ, USA.\', \'CRS Clinical Research Services Mannheim GmbH, Mannheim, Germany.\', \'University of Texas Medical Branch, Galveston, TX, USA.\', \'Pfizer, Pearl River, NY, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41586-020-2814-7
?:doi
?:hasPublicationType
?:journal
  • Nature
is ?:pmid of
?:pmid
?:pmid
  • 32998157
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.875
?:rankingScore_hIndex
  • 1052
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32998157>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32998157>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all